Related Experiment Video
Updated: Jun 19, 2026

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
Published on: October 7, 2011
Structure-Guided Mutagenesis Targeting Interactions between pp150 Tegument Protein and Small Capsid Protein Identify
Abstract:
Human cytomegalovirus (HCMV) replication relies on a nucleocapsid coat of the 150kDa, subfamily-specific tegument phosphoprotein (pp150) to regulate cytoplasmic virion maturation. While recent structural studies revealed pp150-capsid interactions, the role of specific amino-acids involved in these interactions have not been established experimentally. In this study, pp150 and the small capsid protein (SCP), one of pp150's binding partners found atop the major capsid protein (MCP), were subjected to mutational and structural analyses. Mutations to clusters of polar or hydrophobic residues along the pp150-SCP interface abolished viral replication, with no replication detected in mutant virus-infected cells. Notably, a single point mutation at the pp150-MCP interface significantly attenuated viral replication, unlike the situation of pp150-deletion mutation where capsids degraded outside host nuclei. These functionally significant mutations targeting pp150-capsid interactions, particularly the pp150 K255E replication-attenuated mutant, can be explored to overcome the historical challenges of developing effective antivirals and vaccines against HCMV infection.
Insights
Mutations in human cytomegalovirus (HCMV) phosphoprotein pp150
Area of Science:
- Virology
- Molecular Biology
- Structural Biology
Background:
- Human cytomegalovirus (HCMV) replication depends on the tegument phosphoprotein pp150 for cytoplasmic virion maturation.
- Previous studies identified pp150-capsid interactions, but the roles of specific amino acids were unconfirmed.
- The small capsid protein (SCP) and major capsid protein (MCP) are key binding partners of pp150.
Conclusions:
- Specific amino acids within pp150 are critical for regulating HCMV replication through capsid interactions.
- Targeting pp150-capsid interfaces, particularly the K255E mutant, offers a promising strategy for developing HCMV antivirals and vaccines.
- Understanding these interactions is key to overcoming challenges in HCMV therapeutic development.

